The Role of SNHG15 in the Pathogenesis of Hepatocellular Carcinoma.
SNHG15
cancer
carcinoma
hepatocarcinogenesis
hepatocellular
lncRNA
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
06 May 2022
06 May 2022
Historique:
received:
05
03
2022
revised:
18
04
2022
accepted:
03
05
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
29
5
2022
Statut:
epublish
Résumé
Long non-coding RNAs (lncRNAs) are transcripts of more than 200 nucleotides which cannot be translated into proteins. Small nucleolar RNA host gene 15 (SNHG15) is a lncRNA whose dysregulation has been found to have an important impact on carcinogenesis and affect the prognosis of cancer patients in various cancer types. Hepatocellular carcinoma (HCC) is one of the most common cancers with a poor long-term prognosis, while the best prognostic factor of the disease is its early diagnosis and surgery. Consequently, the investigation of the mechanisms of hepatocarcinogenesis, as well as the discovery of efficient molecular markers and therapeutic targets are of great significance. An extensive literature search was performed in MEDLINE in order to identify clinical studies that tried to reveal the role of SNHG15 in HCC. We used keywords such as 'HCC', 'hepatocellular carcinoma', 'SNHG15' and 'clinical study'. Finally, we included four studies written in English, published during the period 2016-2021. It was revealed that SNHG15 is related to the appearance of HCC via different routes and its over-expression affects the overall survival of the patients. More assays are required in order to clarify the potential role of SNHG15 as a prognostic tool and therapeutic target in HCC.
Identifiants
pubmed: 35629174
pii: jpm12050753
doi: 10.3390/jpm12050753
pmc: PMC9145272
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Biochem Biophys Res Commun. 2018 Jan 8;495(2):1594-1600
pubmed: 29217194
Oncol Lett. 2015 Feb;9(2):955-963
pubmed: 25624916
Breast Cancer. 2014 Sep;21(5):515-21
pubmed: 25038622
Gene. 2019 Jul 15;705:44-50
pubmed: 30981837
Oncol Rep. 2017 Nov;38(5):3265-3277
pubmed: 29048682
Cancers (Basel). 2021 Jun 17;13(12):
pubmed: 34204242
World J Gastroenterol. 2019 Oct 14;25(38):5789-5799
pubmed: 31636472
Oncotarget. 2016 Aug 9;7(32):51713-51719
pubmed: 27421138
G Chir. 2019 Nov-Dec;40(6):463-480
pubmed: 32007108
J Hepatocell Carcinoma. 2022 Mar 30;9:233-263
pubmed: 35388357
Clin Exp Med. 2022 Feb;22(1):65-74
pubmed: 34146196
PLoS One. 2016 Oct 25;11(10):e0164804
pubmed: 27780223
Am J Transl Res. 2016 Dec 15;8(12):5141-5150
pubmed: 28077991
Tumour Biol. 2016 May;37(5):6801-12
pubmed: 26662309
Am J Case Rep. 2014 Aug 17;15:343-7
pubmed: 25129420
J Cell Biochem. 2012 Jun;113(6):2167-77
pubmed: 22492270
J Oncol. 2020 Jul 15;2020:3417036
pubmed: 32733556
Cancer Res. 2014 Sep 1;74(17):4752-61
pubmed: 24958469
Biochem Biophys Res Commun. 2019 Jun 4;513(3):669-674
pubmed: 30982576
World J Gastroenterol. 2017 Aug 7;23(29):5282-5294
pubmed: 28839428
Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14452-7
pubmed: 11734645
J BUON. 2018 Jul-Aug;23(4):846-861
pubmed: 30358185
Eur Rev Med Pharmacol Sci. 2014 Jul;18(13):1930-6
pubmed: 25010625
Pathol Oncol Res. 2020 Apr;26(2):599-603
pubmed: 30661224
Int J Mol Sci. 2018 Apr 27;19(5):
pubmed: 29702599
J Pers Med. 2021 Mar 22;11(3):
pubmed: 33809844
Pharmacol Ther. 2014 Feb;141(2):160-71
pubmed: 24121058
Oncotarget. 2016 Jul 12;7(28):44505-44521
pubmed: 27283986
PLoS One. 2011;6(11):e28103
pubmed: 22132221
Lancet. 2017 Jan 7;389(10064):56-66
pubmed: 27932229
Oncotarget. 2015 Mar 30;6(9):7123-35
pubmed: 25704882
Eur Rev Med Pharmacol Sci. 2016 May;20(9):1720-4
pubmed: 27212162
Oncotarget. 2014 Apr 30;5(8):2318-29
pubmed: 24810858
Cancer Med. 2019 May;8(5):2404-2413
pubmed: 30945457
Onco Targets Ther. 2018 Dec 19;12:101-111
pubmed: 30588034
Int J Oncol. 2018 Jul;53(1):384-394
pubmed: 29750422
Gastroenterology. 2007 Jun;132(7):2557-76
pubmed: 17570226
Gut. 2009 Oct;58(10):1399-409
pubmed: 19528037
IUBMB Life. 2021 Feb;73(2):349-361
pubmed: 33372376
Cell Prolif. 2020 Jan;53(1):e12716
pubmed: 31774607
J Cell Biochem. 2019 Dec;120(12):19775-19783
pubmed: 31310393
Medicina (Kaunas). 2019 Nov 21;55(12):
pubmed: 31766556
BMC Cancer. 2009 Nov 03;9:389
pubmed: 19886989
Oncotarget. 2015 May 10;6(13):10840-52
pubmed: 25912306
Biomed Res Int. 2018 Jul 9;2018:8126208
pubmed: 30105249
Hepatology. 2011 Mar;53(3):1020-2
pubmed: 21374666
Oncotarget. 2017 Aug 18;8(48):84153-84167
pubmed: 29137412
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Cell Biochem. 2019 Apr;120(4):6120-6126
pubmed: 30623483
Eur Rev Med Pharmacol Sci. 2018 Oct;22(20):6838-6844
pubmed: 30402848
J Biomed Sci. 2017 Jul 18;24(1):46
pubmed: 28720111
BMC Cancer. 2020 Nov 26;20(1):1156
pubmed: 33243205
Gut Liver. 2016 May 23;10(3):332-9
pubmed: 27114433
Mol Cancer. 2011 Apr 13;10:38
pubmed: 21489289
Oncogene. 2012 Oct 25;31(43):4577-87
pubmed: 22266873